When was Deepcell founded?

Deepcell was founded in 2017 and raised its 1st funding round within a year of its incorporation.

Where is Deepcell located?

Deepcell is headquartered in Menlo Park, United States.

Who is the current CEO of Deepcell?

Maddison Masaeli of Deepcell. They have also founded 1 company.

How many employees does Deepcell have?

As of Jun 30, 2026, the latest employee count at Deepcell is 32.

Is Deepcell a funded company?

Deepcell is a funded company, having raised a total of $123M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2017.

When was the latest funding round of Deepcell?

Deepcell's latest funding was a $***** Series C round on Oct 14, 2022, with participation from 0 investor. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $4B in funding in 2026 to date.

Where does Deepcell rank among its competitors?

Deepcell ranks 24th amongst 223 active competitors, of which 68 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was DeepWise, which secured an undisclosed amount in Jun, 2026.

Who are the top competitors of Deepcell?

Deepcell's top competitors include PathAI, Aiforia and Proscia. Among them, DeepWise secured the most recent funding round in June, 2026.

Deepcell - 2026 Company Profile, Team, Funding & Competitors

Company Details

AI-powered single cell classification and isolation technology for clinical research. The company is pioneering proprietary methods in single cell analysis by combining innovations in microfluidics, optics, and AI for magnifying insights into cells phenotype and function to address research questions across biology.

Website: www.deepcell.com/
Social
Email ID: *****@deepcellbio.com
Part Of

Key Metrics

Founded Year

2017

Location

Menlo Park, United States

Stage

Series C

Total Funding

$123M in 5 rounds

Latest Funding Round

Series C, Oct 14, 2022, $*****

Investors

Andreessen Horowitz & 11 more

Ranked

24^th among 223 active competitors

Employee Count

32 as on Jun 30, 2026

Similar Companies

PathAI & 214 more

View Deepcell's full profile

Deepcell has raised a total funding of $123M over 5 rounds. Its first funding round was on 2017. Deepcell has 10 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Deepcell:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 14, 2022	4225838	Series C	1435042	9518193	5225212	7197543
Mar 17, 2022	9514102	Series B	8885199	7337571	2274852	Horizons Ventures & 6 more
Dec 07, 2020	4001276	Series A	8421609	5342826	Bow Capital	Andreessen Horowitz & 4 more

Access funding benchmarks and valuations. Sign up today!

View details of Deepcell's funding rounds and investors

The founders of Deepcell are Maddison Masaeli and Mahyar Salek.

Here are the details of Deepcell's key team members:

Maddison Masaeli: Co-Founder & CEO of Deepcell and founder of 2 other companies, Basecell and Deepcell.
Contact Info: 1 email address
Mahyar Salek: Co-Founder & CTO of Deepcell and founder of 2 other companies, Basecell and Deepcell.
Contact Info: 1 email address

View details of Deepcell's Founder profiles and Board Members

Deepcell's employee count trend

Deepcell has 32 employees as of Jun 26. Here is Deepcell's employee count trend over the years:

Uncover Deepcell's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Deepcell include PathAI, Aiforia and Proscia. Here is the list of Top 10 competitors of Deepcell, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, General Atlantic & 22 others	72/100
2nd	Aiforia 2014, Helsinki (Finland), Public	Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas	$23M	Ascend Capital Partners, Businessfinland & 8 others	66/100
3rd	Proscia 2014, Philadelphia (United States), Acquired	Provider of an AI and cloud-based digital pathology solution for cancer diagnosis	$129M	Triangle Peak Partners, TEDCO & 22 others	62/100
4th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$50.4M	ARUP Laboratories, Zoetis & 2 others	62/100
5th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	61/100
6th	Aignostics 2018, Berlin (Germany), Series B	Developer of artificial intelligence software for biomedical image analysis applications	$53.9M	Wellington Partners Venture Capital, Boehringer Ingelheim Venture Fund ... & 9 others	61/100
7th	DeepWise 2017, Beijing (China), Series D	Developer of AI-based radiology image solutions primarily for cancer diagnosis	$115M	Legend Capital, CICC Capital & 18 others	59/100
8th	Mindpeak 2017, Hamburg (Germany), Series A	Provider of AI-based pathological analysis platform	$18.3M	IFB Innovationsstarter, ZEISS & 28 others	59/100
9th	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	Accomplice, MassMutual & 12 others	57/100
10th	HistoIndex 2010, Singapore (Singapore), Series A	Provider of AI powered digital pathology platform for fibrosis analysis	$6.89M	OCBC, SEEDS Capital & 2 others	57/100
24th	Deepcell 2017, Menlo Park (United States), Series C	AI-powered single cell classification and isolation technology for clinical research	$123M	DCVC, Fifty Years & 10 others	48/100